40 CFR Part 799, Subpart H - Health Effects Test Guidelines
prev | next
- § 799.9110 — TSCA acute oral toxicity.
- § 799.9120 — TSCA acute dermal toxicity.
- § 799.9130 — TSCA acute inhalation toxicity.
- § 799.9135 — TSCA acute inhalation toxicity with histopathology.
- § 799.9305 — TSCA Repeated dose 28-day oral toxicity study in rodents.
- § 799.9310 — TSCA 90-day oral toxicity in rodents.
- § 799.9325 — TSCA 90-day dermal toxicity.
- § 799.9346 — TSCA 90-day inhalation toxicity.
- § 799.9355 — TSCA reproduction/developmental toxicity screening test.
- § 799.9365 — TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test.
- § 799.9370 — TSCA prenatal developmental toxicity.
- § 799.9380 — TSCA reproduction and fertility effects.
- § 799.9410 — TSCA chronic toxicity.
- § 799.9420 — TSCA carcinogenicity.
- § 799.9430 — TSCA combined chronic toxicity/carcinogenicity.
- § 799.9510 — TSCA bacterial reverse mutation test.
- § 799.9530 — TSCA in vitro mammalian cell gene mutation test.
- § 799.9537 — TSCA in vitro mammalian chromosome aberration test.
- § 799.9538 — TSCA mammalian bone marrow chromosomal aberration test.
- § 799.9539 — TSCA mammalian erythrocyte micronucleus test.
- § 799.9620 — TSCA neurotoxicity screening battery.
- § 799.9630 — TSCA developmental neurotoxicity.
- § 799.9748 — TSCA metabolism and pharmacokinetics
- § 799.9780 — TSCA immunotoxicity.
Source:
62 FR 43824, Aug. 15, 1997, unless otherwise noted.
Title 40 published on 2015-07-01.
No entries appear in the Federal Register after this date, for 40 CFR Part 799.